NEW YORK (GenomeWeb) – Having completed the full commercial launch of its ultra-fast thermal cycler for research use earlier this year, BJS Biotechnologies is now looking to push the platform into clinical use, including near-patient testing.
To that end, the UK-based company in March said that it is spearheading a consortium that aims develop a rapid, point-of-care sepsis test on the platform.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.